Two neurotransmitter-degrading enzymes (AChE and BChE) and the β-amyloid formation enzyme (BACE-1) were investigated to control Alzheimer’s disease. This evidence concerns the gene BACE1 and early-onset autosomal dominant Alzheimer disease.